Most recently, it's been identified that conolidine and the above mentioned derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar spots as classical opioid receptors, it binds to some big selection of endogenous opioids. Contrary to most opioid receptors, this receptor acts as a scavenger https://alexm296det9.losblogos.com/profile